UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012088
Receipt number R000012285
Scientific Title Questionnaire Survey of Patients Using Accu-chek mobile
Date of disclosure of the study information 2013/10/23
Last modified on 2020/12/24 11:26:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Questionnaire Survey of Patients Using Accu-chek mobile

Acronym

QSACM

Scientific Title

Questionnaire Survey of Patients Using Accu-chek mobile

Scientific Title:Acronym

QSACM

Region

Japan


Condition

Condition

diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the opinions of both patients and medical providers on Accu-check mobile after providing the machine to patients

Basic objectives2

Others

Basic objectives -Others

Assessment of manipulation by patients and medical providers, and effect on quality of life of patients

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Evaluation on manipulation of SMBG devices (needle and monitor),
2) Impact on psychological and physical stress,
comparing SMBG devices currently in use

Key secondary outcomes

1) Function of SMBG devices that would be found from the point of medical providers
2) Discrepancy of needs of patients and medical providers
3) Evaluation of Accu-chek mobile by medical providers
4) Possibility of lowering efforts by medical providers


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

SMBG machine and lancet device currently prescribed / Accu-chek mobile

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

patients with diabetes mellitus and receiving insulin or GLP-1 receptor agonist treatment under SMBG (self-monitoring of blood glucose)

Key exclusion criteria

patients who don&#39;t agree to this study

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Masafumi
Middle name
Last name Matsuda

Organization

Saitama Medical Center, Saitama Medical University

Division name

Depertment of Endocrinology and Diaebtes

Zip code

350-8550

Address

1981 Kamoda, Kawagoe-shi, Saitama-ken

TEL

+81-49-228-3564

Email

matsudam-ind@umn.ac.jp


Public contact

Name of contact person

1st name Masafumi
Middle name
Last name Matsuda

Organization

Saitama Medical Center, Saitama Medical University

Division name

Depertment of Endocrinology and Diaebtes

Zip code

350-8550

Address

1981 Kamoda, Kawagoe-shi, Saitama-ken

TEL

+81-49-228-3564

Homepage URL


Email

matsudam-ind@umin.ac.jp


Sponsor or person

Institute

Saitama Medical Center, Saitama Medical University
Roche Diagnostics Japan

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical Center, Saitama Medical University
Saitama Medical Center, Saitama Medical University
Roche Diagnostics Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Saitama Medical Center, Saitama Medical Univ.

Address

1981, Kamoda, Kawagoe-shi, Saitama-ken, JAPAN

Tel

049-228-3902

Email

smcrinri@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学総合医療センター


Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 05 Month 01 Day

Date of IRB

2013 Year 06 Month 21 Day

Anticipated trial start date

2013 Year 08 Month 01 Day

Last follow-up date

2013 Year 12 Month 31 Day

Date of closure to data entry

2014 Year 01 Month 31 Day

Date trial data considered complete

2014 Year 12 Month 31 Day

Date analysis concluded

2015 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2013 Year 10 Month 21 Day

Last modified on

2020 Year 12 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012285


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name